Orian J
J Neuroimmune Pharmacol. 2025; 20(1):14.
PMID: 39904925
PMC: 11794395.
DOI: 10.1007/s11481-025-10182-w.
Beura S, Panigrahi A, Yadav P, Kulkarni P, Lakhanpal V, Singh B
Mol Neurobiol. 2024; 62(4):4802-4836.
PMID: 39482419
DOI: 10.1007/s12035-024-04589-4.
Mehdi-Alamdarlou S, Ahmadi F, Shahbazi M, Azadi A, Ashrafi H
Mol Biol Rep. 2023; 50(5):4675-4686.
PMID: 37022526
PMC: 10078055.
DOI: 10.1007/s11033-023-08322-7.
Orian J, DSouza C, Kocovski P, Krippner G, Hale M, Wang X
Front Immunol. 2021; 12:620963.
PMID: 33679764
PMC: 7933211.
DOI: 10.3389/fimmu.2021.620963.
Pankratz S, Bittner S, Kehrel B, Langer H, Kleinschnitz C, Meuth S
Int J Mol Sci. 2016; 17(10).
PMID: 27754414
PMC: 5085754.
DOI: 10.3390/ijms17101723.
Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes.
Chao B, Lepeak L, Leal T, Robins H
Thrombosis. 2011; 2011:530183.
PMID: 22084664
PMC: 3195390.
DOI: 10.1155/2011/530183.
Role of platelets in neuroinflammation: a wide-angle perspective.
Horstman L, Jy W, Ahn Y, Zivadinov R, Maghzi A, Etemadifar M
J Neuroinflammation. 2010; 7:10.
PMID: 20128908
PMC: 2829540.
DOI: 10.1186/1742-2094-7-10.
Evidence of platelet activation in multiple sclerosis.
Sheremata W, Jy W, Horstman L, Ahn Y, Alexander J, Minagar A
J Neuroinflammation. 2008; 5:27.
PMID: 18588683
PMC: 2474601.
DOI: 10.1186/1742-2094-5-27.
Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial.
Robins H, ONeill A, Gilbert M, Olsen M, Sapiente R, Berkey B
Cancer Chemother Pharmacol. 2007; 62(2):227-33.
PMID: 17882417
PMC: 2519795.
DOI: 10.1007/s00280-007-0596-3.
Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021.
Robins H, Won M, Seiferheld W, Schultz C, Choucair A, Brachman D
Neuro Oncol. 2006; 8(1):47-52.
PMID: 16443947
PMC: 1871929.
DOI: 10.1215/S1522851705000311.
Thromboembolic complications associated with brain tumors.
Sawaya R, Ligon B
J Neurooncol. 1994; 22(2):173-81.
PMID: 7745469
DOI: 10.1007/BF01052892.
Platelet stickiness in multiple sclerosis.
Millac P
Dtsch Z Nervenheilkd. 1967; 191(1):74-9.
PMID: 6051946
DOI: 10.1007/BF00243772.
Red blood cell fragility in multiple sclerosis.
CASPARY E, Sewell F, Field E
Br Med J. 1967; 2(5552):610-1.
PMID: 6025599
PMC: 1842120.
DOI: 10.1136/bmj.2.5552.610.
Platelet stickiness in multiple sclerosis.
Millar J, Merrett J, DALBY A
J Neurol Neurosurg Psychiatry. 1966; 29(3):187-9.
PMID: 5937630
PMC: 496015.
DOI: 10.1136/jnnp.29.3.187.
A biochemical approach to the problem of multiple sclerosis.
Thompson R
Proc R Soc Med. 1966; 59(3):269-76.
PMID: 5909771
PMC: 1900742.
Further studies on platelet adhesiveness and serum cholesteryl linoleate levels in multiple sclerosis.
Sanders H, Thompson R, Wright H, ZILKHA K
J Neurol Neurosurg Psychiatry. 1968; 31(4):321-5.
PMID: 5684391
PMC: 496368.
DOI: 10.1136/jnnp.31.4.321.
Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis.
Gul S, Smith A, Thompson R, Wright H, ZILKHA K
J Neurol Neurosurg Psychiatry. 1970; 33(4):506-10.
PMID: 5505678
PMC: 493509.
DOI: 10.1136/jnnp.33.4.506.
